RSPO1 and neoplasm: These matrices are then supplemented with tumor-selective medium containing a well-defined mix of growth factors, such as R-spondin (RSPO), WNT3A, epidermal growth factor (EGF) and bone morphogenetic proteins (BMP) inhibitor Noggin.